AAP updates recommendations for meningococcal vaccines

July 28, 2014
AAP updates recommendations for meningococcal vaccines
New recommendations are presented for meningococcal vaccination in a policy statement published online July 28 in Pediatrics.

(HealthDay)—New recommendations are presented for meningococcal vaccination in a policy statement published online July 28 in Pediatrics.

Michael T. Brady, M.D., from the American Academy of Pediatrics (AAP) Committee on Infectious Diseases, and colleagues updated recommendations for use of meningococcal vaccines in children and adolescents.

According to the report, in the absence of contraindications, an age-appropriate meningococcal conjugate is preferred to the meningococcal polysaccharide vaccine. Adolescents should be routinely immunized at age 11 or 12 years and given a booster at age 16 with quadrivalent conjugated meningococcal vaccine; those who receive their first dose at 13 to 15 years should receive a booster at age 16 to 18 years. A booster is not necessary for those who receive their first dose at or after age 16 years. For individuals at increased risk of , a two-dose primary series should be administered to those aged 2 to 55 years, and a four-dose primary series should be administered to children aged 2 to 18 months. HIV-infected children should be given a two-dose primary series with a single booster dose; children older than 2 years at risk of meningococcal disease should have a primary series that includes two doses of quadrivalent meningococcal conjugate vaccine. Children at persistent risk of meningococcal disease should be given regular boosters.

"This policy statement updates the AAP recommendations for use of meningococcal vaccines in children and adolescents," the authors write.

More information: Abstract
Full Text

Related Stories

Booster dose of new meningitis vaccine may be beneficial

September 23, 2013

A study of 4CMenB, a new vaccine to protect against meningitis B bacteria (which can cause potentially fatal bacterial meningitis in children), shows that waning immunity induced by infant vaccination can be overcome by a ...

Risk of invasive meningococcal disease up with HIV/AIDS

October 29, 2013

(HealthDay)—In New York City, people living with HIV/AIDS (PLWHA) are at increased risk of contracting invasive meningococcal disease (IMD), according to a study published online Oct. 29 in the Annals of Internal Medicine.

AAP approves childhood immunization schedules for 2014

January 31, 2014

(HealthDay)—The recommended childhood and adolescent immunization schedules for 2014 have been approved, according to an American Academy of Pediatrics (AAP) policy statement published in the Feb. 1 issue of Pediatrics.

Recommended for you

Experimental MERS vaccine shows promise in animal studies

July 28, 2015

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. ...

Can social isolation fuel epidemics?

July 21, 2015

Conventional wisdom has it that the more people stay within their own social groups and avoid others, the less likely it is small disease outbreaks turn into full-blown epidemics. But the conventional wisdom is wrong, according ...

Lack of knowledge on animal disease leaves humans at risk

July 20, 2015

Researchers from the University of Sydney have painted the most detailed picture to date of major infectious diseases shared between wildlife and livestock, and found a huge gap in knowledge about diseases which could spread ...

IBD genetically similar in Europeans and non-Europeans

July 20, 2015

The first genetic study of inflammatory bowel disease (IBD) to include individuals from diverse populations has shown that the regions of the genome underlying the disease are consistent around the world. This study, conducted ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.